NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality
Authors
STUPP, Roger, Eric T WONG, Andrew A KANNER, David STEINBERG, Herbert ENGELHARD, Volkmar HEIDECKE, Eilon D KIRSON, Sophie TAILLIBERT, Frank LIEBERMANN, Vladimír DBALÝ, Zvi RAM, J Lee VILLANO, Nikolai RAINOV, Uri WEINBERG, David SCHIFF, Lara KUNSCHNER, Jeffrey RAIZER, Jerome HONNORAT, Andrew SLOAN, Mark MALKIN, Joseph C LANDOLFI, Franz PAYER, Maximilian MEHDORN, Robert J WEIL, Susan C PANNULLO, Manfred WESTPHAL, Martin SMRČKA, Lawrence CHIN, Herwig KOSTRON, Silvia HOFER, Jeffrey BRUCE, Rees COSGROVE, Nina PALEOLOGOUS, Yoram PALTI and Philip H GUTIN
Edition
European Journal of Cancer, Oxford, UK, ELSEVIER, 2012, 0959-8049
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30000 3. Medical and Health Sciences
Country of publisher
United Kingdom of Great Britain and Northern Ireland
NovoTTF-100A is a portable device delivering low-intensity, intermediate frequency electric fields via non-invasive, transducer arrays. Tumour Treatment Fields (TTF), a completely new therapeutic modality in cancer treatment, physically interfere with cell division.
STUPP, Roger, Eric T WONG, Andrew A KANNER, David STEINBERG, Herbert ENGELHARD, Volkmar HEIDECKE, Eilon D KIRSON, Sophie TAILLIBERT, Frank LIEBERMANN, Vladimír DBALÝ, Zvi RAM, J Lee VILLANO, Nikolai RAINOV, Uri WEINBERG, David SCHIFF, Lara KUNSCHNER, Jeffrey RAIZER, Jerome HONNORAT, Andrew SLOAN, Mark MALKIN, Joseph C LANDOLFI, Franz PAYER, Maximilian MEHDORN, Robert J WEIL, Susan C PANNULLO, Manfred WESTPHAL, Martin SMRČKA, Lawrence CHIN, Herwig KOSTRON, Silvia HOFER, Jeffrey BRUCE, Rees COSGROVE, Nina PALEOLOGOUS, Yoram PALTI and Philip H GUTIN. NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality. European Journal of Cancer. Oxford, UK: ELSEVIER, 2012, vol. 48, No 14, p. 2192-2202. ISSN 0959-8049. Available from: https://dx.doi.org/10.1016/j.ejca.2012.04.011.
@article{1082946, author = {Stupp, Roger and Wong, Eric T and Kanner, Andrew A and Steinberg, David and Engelhard, Herbert and Heidecke, Volkmar and Kirson, Eilon D and Taillibert, Sophie and Liebermann, Frank and Dbalý, Vladimír and Ram, Zvi and Villano, J Lee and Rainov, Nikolai and Weinberg, Uri and Schiff, David and Kunschner, Lara and Raizer, Jeffrey and Honnorat, Jerome and Sloan, Andrew and Malkin, Mark and Landolfi, Joseph C and Payer, Franz and Mehdorn, Maximilian and Weil, Robert J and Pannullo, Susan C and Westphal, Manfred and Smrčka, Martin and Chin, Lawrence and Kostron, Herwig and Hofer, Silvia and Bruce, Jeffrey and Cosgrove, Rees and Paleologous, Nina and Palti, Yoram and Gutin, Philip H}, article_location = {Oxford, UK}, article_number = {14}, doi = {http://dx.doi.org/10.1016/j.ejca.2012.04.011}, keywords = {Glioblastoma - Brain tumour - Chemotherapy - Randomised trial}, language = {eng}, issn = {0959-8049}, journal = {European Journal of Cancer}, title = {NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality}, volume = {48}, year = {2012} }
TY - JOUR ID - 1082946 AU - Stupp, Roger - Wong, Eric T - Kanner, Andrew A - Steinberg, David - Engelhard, Herbert - Heidecke, Volkmar - Kirson, Eilon D - Taillibert, Sophie - Liebermann, Frank - Dbalý, Vladimír - Ram, Zvi - Villano, J Lee - Rainov, Nikolai - Weinberg, Uri - Schiff, David - Kunschner, Lara - Raizer, Jeffrey - Honnorat, Jerome - Sloan, Andrew - Malkin, Mark - Landolfi, Joseph C - Payer, Franz - Mehdorn, Maximilian - Weil, Robert J - Pannullo, Susan C - Westphal, Manfred - Smrčka, Martin - Chin, Lawrence - Kostron, Herwig - Hofer, Silvia - Bruce, Jeffrey - Cosgrove, Rees - Paleologous, Nina - Palti, Yoram - Gutin, Philip H PY - 2012 TI - NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality JF - European Journal of Cancer VL - 48 IS - 14 SP - 2192-2202 EP - 2192-2202 PB - ELSEVIER SN - 09598049 KW - Glioblastoma - Brain tumour - Chemotherapy - Randomised trial N2 - NovoTTF-100A is a portable device delivering low-intensity, intermediate frequency electric fields via non-invasive, transducer arrays. Tumour Treatment Fields (TTF), a completely new therapeutic modality in cancer treatment, physically interfere with cell division. ER -
STUPP, Roger, Eric T WONG, Andrew A KANNER, David STEINBERG, Herbert ENGELHARD, Volkmar HEIDECKE, Eilon D KIRSON, Sophie TAILLIBERT, Frank LIEBERMANN, Vladimír DBALÝ, Zvi RAM, J Lee VILLANO, Nikolai RAINOV, Uri WEINBERG, David SCHIFF, Lara KUNSCHNER, Jeffrey RAIZER, Jerome HONNORAT, Andrew SLOAN, Mark MALKIN, Joseph C LANDOLFI, Franz PAYER, Maximilian MEHDORN, Robert J WEIL, Susan C PANNULLO, Manfred WESTPHAL, Martin SMRČKA, Lawrence CHIN, Herwig KOSTRON, Silvia HOFER, Jeffrey BRUCE, Rees COSGROVE, Nina PALEOLOGOUS, Yoram PALTI and Philip H GUTIN. NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality. \textit{European Journal of Cancer}. Oxford, UK: ELSEVIER, 2012, vol.~48, No~14, p.~2192-2202. ISSN~0959-8049. Available from: https://dx.doi.org/10.1016/j.ejca.2012.04.011.